Patients with polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT) have better visual acuity (VA) 1 year after treatment in those patients with better pre-treatment visual acuity, smaller lesion size, and absence of subfoveal lesions, according to a new study. Polypoidal choroidal vasculopathy (PCV) is a condition...

A review of patients from India with polypoidal choroidal vasculopathy finds that the disease is more common in men than women, and that thermal laser and photodynamic therapy PDT were both safe and effective therapies. Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, recurrent, serosanguinous pigment epithelial...

To evaluate the short-term efficacy of photodynamic therapy (PDT) for steroid-associated chronic or recurrent central serous chorioretinopathy (CSC). Design Interventional case series. CSC is characterized by the accumulation of subretinal fluid (SRF) at the macula and is a common condition in young adults, especially in men with a so-called...

Outcomes following photodynamic therapy (PDT) combined with intravitreal Avastin (bevacizumab) injection were superior to PDT monotherapy in patients with polypoidal choroidal vasculopathy (PCV), according to a new study. Polypoidal chodoridal vasculopathy (PCV) is characterized by a complex of branching vascular networks terminating in...

After 24 months of follow-up, patients treated with intravitreal Avastin (bevacizumab, IVB) have superior outcomes compared to patients treated with photodynamic therapy (PDT) for myopic choroidal neovascularisation (mCNV), according to a new study. Extreme myopia may result in degenerative changes of the retina. These degenerative changes may...

The addition of standard-fluence verteporfin photodynamic therapy (PDT) delivered on the first day to a Lucentis (ranibizumab) regimen for choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) does not improve outcomes at 1 year of follow-up compared with Lucentis monotherapy, according to a new study. Despite...

Patients with central serous chorioretinopathy (CSC) undergoing reduced-fluence photodynamic therapy (PDT) recover faster than patients undergoing focal laser photocoagulation. CSC is characterized by the accumulation of subretinal fluid (SRF) at the macula and is a common condition in young adults, especially in men with a so-called type A...

Combination therapies generated greater visual acuity gains with fewer reinjections compared with monotherapy in a phase 2 study of patients with exudative age-related macular degeneration. In the phase 2 RADICAL (Reduced fluence Visudyne anti-VEGF-dexamethasone in combination for AMD lesions) study, mean gain in visual acuity from baseline in 3...

Combined verteporfin photodynamic therapy (PDT) and Lucentis (ranibizumab) shows promising results for the treatment of polypoidal choroidal vasculopathy (PCV). Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, recurrent, serosanguinous pigment epithelial detachment (PED), and neurosensory retinal detachment due...

Combined therapy using intravitreal Avastin (bevacizumab) followed by photodynamic therapy (PDT) is safe and effective in eyes with retinal angiomatous proliferation (RAP), according to a new study. Retinal angiomatous proliferation is a distinct form of neovascular age-related macular degeneration (AMD) associated with angiomatous...